{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T18:03:27Z","timestamp":1791655407157,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T00:00:00Z","timestamp":1661472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY029594"],"award-info":[{"award-number":["R01 EY029594"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stanley M. Truhlsen Family Foundation"},{"DOI":"10.13039\/100005426","name":"Association for Research in Vision and Ophthalmology","doi-asserted-by":"publisher","award":["Mallinckrodt Young Investigator Award"],"award-info":[{"award-number":["Mallinckrodt Young Investigator Award"]}],"id":[{"id":"10.13039\/100005426","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Retin Vitr"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Primary vitreoretinal lymphoma (PVRL) is an aggressive lymphoma that may present with protean features and represents a diagnostic challenge. Given that patients with PVRL are at high risk of CNS involvement with a high mortality and morbidity rate, prompt diagnosis is crucial to initiate treatment early in the disease course. A multimodality imaging approach including fundus photography, fundus autofluorescence (FAF), optical coherence tomography (OCT), fluorescein and indocyanine angiography, and electroretinography (ERG) can provide information to establish a diagnosis and provide objective measures for management. We review key findings seen via these imaging modalities in patients with PVRL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Observations<\/jats:title>\n                <jats:p>Fundus photography can highlight commonly seen patterns of PVRL including vitritis, subretinal disease, retinal pigment epithelial (RPE) abnormalities, optic nerve edema, retinal detachment, and less typical retinitis-like lesions. FAF can identify characteristic patterns of hyper- and hypoautofluorescent signal abnormalities in the macula. Spectral-domain OCT will demonstrate vitreous cells, RPE nodularity, and hyperreflectivity of the outer retina. The presence of a hyper-reflective band in the subretinal space and infiltrates between the RPE and Bruch\u2019s membrane can assist in distinguishing PVRL from choroidal lymphoma. Vertical hyperreflective columns (VHRLs) are another pertinent finding that may represent microinfiltrates of the tumor. OCT has proven to be a particularly useful modality in assessing the progress of treatment in PVRL. Fluorescein angiography can show RPE changes, which include granularity, late staining at the RPE level, and blockage. Indocyanine green angiography (ICGA) primarily shows hypocyanescence, which corresponds to PVRL lesions on fundus photography and may occur secondary to loss of RPE and choriocapillaris.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>While PVRL remains a challenging disease to diagnose and follow, the use of a multimodality imaging approach may assist in establishing a diagnosis. Because of the anatomic spaces PVRL may affect, fundus photography, OCT, FAF, angiography, and ERG can identify key characteristics of the disease, differentiate PVRL from other diseases, and provide baseline information for targeted systemic and local therapies. Further assessment of anatomic and functional targets will aid our clinical application of multimodal imaging in the management of PVRL.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40942-022-00405-0","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T13:03:04Z","timestamp":1661518984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Multimodal diagnostic imaging in primary vitreoretinal lymphoma"],"prefix":"10.1186","volume":"8","author":[{"given":"Lucy T.","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7319-7842","authenticated-orcid":false,"given":"Ye","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey L.","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Voloschin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,26]]},"reference":[{"issue":"11","key":"405_CR1","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1634\/theoncologist.2011-0210","volume":"16","author":"CC Chan","year":"2011","unstructured":"Chan CC, Rubenstein JL, Coupland SE, Davis JL, Harbour JW, Johnston PB, et al. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011;16(11):1589\u201399.","journal-title":"Oncologist"},{"issue":"6","key":"405_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1442-9071.2008.01843.x","volume":"36","author":"SE Coupland","year":"2008","unstructured":"Coupland SE, Damato B. Understanding intraocular lymphomas. Clin Exp Ophthalmol. 2008;36(6):564\u201378.","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"405_CR3","first-page":"17","volume":"32","author":"RV Lukas","year":"2018","unstructured":"Lukas RV, Stupp R, Gondi V, Raizer JJ. Primary central nervous system lymphoma-PART 1: Epidemiology, Diagnosis, Staging, and Prognosis. Oncology. 2018;32(1):17\u201322.","journal-title":"Oncology"},{"issue":"6","key":"405_CR4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00417-005-0138-9","volume":"244","author":"K Jahnke","year":"2006","unstructured":"Jahnke K, Korfel A, Komm J, Bechrakis NE, Stein H, Thiel E, et al. Intraocular lymphoma 2000\u20132005: results of a retrospective multicentre trial. Graefes Arch Clin Exp Ophthalmol. 2006;244(6):663\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"3","key":"405_CR5","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1159\/000495284","volume":"141","author":"T Siegal","year":"2019","unstructured":"Siegal T, Bairey O. Primary CNS Lymphoma in the Elderly: the challenge. Acta Haematol. 2019;141(3):138\u201345.","journal-title":"Acta Haematol"},{"key":"405_CR6","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2147\/OPTH.S159014","volume":"13","author":"R Venkatesh","year":"2019","unstructured":"Venkatesh R, Bavaharan B, Mahendradas P, Yadav NK. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges. Clin Ophthalmol. 2019;13:353\u201364.","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"405_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1076\/ocii.8.4.243.6463","volume":"8","author":"N Cassoux","year":"2000","unstructured":"Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Mil\u00e9a D, Gerber S, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8(4):243\u201350.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"405_CR8","first-page":"283","volume":"6","author":"I Araujo","year":"2017","unstructured":"Araujo I, Coupland SE. Primary vitreoretinal lymphoma\u2014a review. Asia Pac J Ophthalmol. 2017;6(3):283\u20139.","journal-title":"Asia Pac J Ophthalmol"},{"issue":"10","key":"405_CR9","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1097\/IAE.0000000000002260","volume":"39","author":"JA Lavine","year":"2019","unstructured":"Lavine JA, Singh AD, Sharma S, Baynes K, Lowder CY, Srivastava SK. Ultra-widefield multimodal imaging of primary vitreoretinal lymphoma. Retina. 2019;39(10):1861\u201371.","journal-title":"Retina"},{"issue":"4","key":"405_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000374121","volume":"1","author":"D Mantopoulos","year":"2015","unstructured":"Mantopoulos D, Cebulla CM. Multimodal imaging of spontaneously shifting primary vitreoretinal lymphoma. Ocular Oncol Pathol. 2015;1(4):237\u201340.","journal-title":"Ocular Oncol Pathol"},{"issue":"3","key":"405_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/09273948.2019.1648835","volume":"29","author":"A Marchese","year":"2021","unstructured":"Marchese A, Agarwal A, Miserocchi E, Giuffr\u00e8 C, Bandello F, Modorati G, et al. Features of retinitis-like lesions in vitreoretinal lymphoma. Ocul Immunol Inflamm. 2021;29(3):440\u20137.","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"405_CR12","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.3928\/23258160-20151027-11","volume":"46","author":"ME Ryan","year":"2015","unstructured":"Ryan ME, Shantha JG, Grossniklaus HE, Yeh S. Secondary vitreoretinal lymphoma masquerading as acute retinal necrosis. Ophthalmic Surg Lasers Imaging Retina. 2015;46(10):1048\u201350.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"1","key":"405_CR13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s40942-021-00327-3","volume":"7","author":"A Rali","year":"2021","unstructured":"Rali A, Xu LT, Craven C, Cohen JB, Yeh S, Grossniklaus HE, et al. Diagnostic retinal biopsy in the management of secondary non-CNS vitreoretinal lymphoma masquerading as viral retinitis: a case report. Int J Retina Vitreous. 2021;7(1):58.","journal-title":"Int J Retina Vitreous"},{"issue":"2","key":"405_CR14","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1097\/IAE.0b013e31829977fa","volume":"34","author":"M Casady","year":"2014","unstructured":"Casady M, Faia L, Nazemzadeh M, Nussenblatt R, Chan CC, Sen HN. Fundus autofluorescence patterns in primary intraocular lymphoma. Retina. 2014;34(2):366\u201372.","journal-title":"Retina"},{"issue":"1","key":"405_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1869-5760-4-7","volume":"4","author":"M Egawa","year":"2014","unstructured":"Egawa M, Mitamura Y, Hayashi Y, Semba K, Naito T. Changes of fundus autofluorescence and spectral-domain optical coherence tomographic findings after treatment of primary intraocular lymphoma. J Ophthalmic Inflamm Infect. 2014;4(1):7.","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"405_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2147\/OPTH.S58114","volume":"8","author":"M Egawa","year":"2014","unstructured":"Egawa M, Mitamura Y, Hayashi Y, Naito T. Spectral-domain optical coherence tomographic and fundus autofluorescence findings in eyes with primary intraocular lymphoma. Clin Ophthalmol. 2014;8:335\u201341.","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"405_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1097\/IAE.0b013e3181b408a2","volume":"30","author":"T Ishida","year":"2010","unstructured":"Ishida T, Ohno-Matsui K, Kaneko Y, Tobita H, Shimada N, Takase H, et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina. 2010;30(1):23\u201332.","journal-title":"Retina"},{"issue":"2","key":"405_CR18","first-page":"133","volume":"37","author":"ZW Huying","year":"2021","unstructured":"Huying ZW, Wenxue G, Ma Y, Ge W, Zhang X, Xiao Y, Peng X. Characteristics of optical coherence tomography in patients with primary vitreoretinal lymphoma. Chinese J Ocular Fundus Dis. 2021;37(2):133\u20137.","journal-title":"Chinese J Ocular Fundus Dis"},{"issue":"1","key":"405_CR19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12886-019-1300-1","volume":"20","author":"H Zhao","year":"2020","unstructured":"Zhao H, Wang X, Mao Y, Peng X. Longitudinal observation of OCT imaging is a valuable tool to monitor primary vitreoretinal lymphoma treated with intravitreal injections of methotrexate. BMC Ophthalmol. 2020;20(1):10.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"405_CR20","first-page":"268","volume":"24","author":"H Keino","year":"2016","unstructured":"Keino H, Okada AA, Watanabe T, Echizen N, Inoue M, Takayama N, et al. Spectral-domain optical coherence tomography patterns in intraocular lymphoma. Ocul Immunol Inflamm. 2016;24(3):268\u201373.","journal-title":"Ocul Immunol Inflamm"},{"issue":"12","key":"405_CR21","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1007\/s00417-016-3395-x","volume":"254","author":"T Saito","year":"2016","unstructured":"Saito T, Ohguro N, Iwahashi C, Hashida N. Optical coherence tomography manifestations of primary vitreoretinal lymphoma. Graefes Arch Clin Exp Ophthalmol. 2016;254(12):2319\u201326.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"10","key":"405_CR22","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/bjophthalmol-2017-311612","volume":"102","author":"RJ Barry","year":"2018","unstructured":"Barry RJ, Tasiopoulou A, Murray PI, Patel PJ, Sagoo MS, Denniston AK, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018;102(10):1362\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"405_CR23","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajo.2008.12.025","volume":"147","author":"C Fardeau","year":"2009","unstructured":"Fardeau C, Lee CP, Merle-B\u00e9ral H, Cassoux N, Bodaghi B, Davi F, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886\u201394.","journal-title":"Am J Ophthalmol"},{"key":"405_CR24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3928\/15428877-20110922-02","volume":"42","author":"F Forooghian","year":"2011","unstructured":"Forooghian F, Merkur AB, White VA, Shen D, Chan CC. High-definition optical coherence tomography features of primary vitreoretinal lymphoma. Ophthal Surg Lasers Imaging. 2011;42:97\u20139.","journal-title":"Ophthal Surg Lasers Imaging"},{"issue":"4","key":"405_CR25","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s12348-012-0072-z","volume":"2","author":"TYA Liu","year":"2012","unstructured":"Liu TYA, Ibrahim M, Bittencourt M, Sepah YJ, Do DV, Nguyen QD. Retinal optical coherence tomography manifestations of intraocular lymphoma. J Ophthal Inflamm Infect. 2012;2(4):215\u20138.","journal-title":"J Ophthal Inflamm Infect"},{"issue":"10","key":"405_CR26","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1038\/eye.2010.111","volume":"24","author":"S Yeh","year":"2010","unstructured":"Yeh S, Wilson DJ. Combination intravitreal rituximab and methotrexate for massive subretinal lymphoma. Eye. 2010;24(10):1625\u20137.","journal-title":"Eye"},{"issue":"3","key":"405_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1080\/09273948.2021.1878233","volume":"29","author":"D Carbonell","year":"2021","unstructured":"Carbonell D, Mahajan S, Chee S-P, Sobolewska B, Agrawal R, B\u00fclow T, et al. Consensus recommendations for the diagnosis of vitreoretinal lymphoma. Ocul Immunol Inflamm. 2021;29(3):507\u201320.","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"405_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaophthalmol.2018.5835","volume":"137","author":"GG De\u00e1k","year":"2019","unstructured":"De\u00e1k GG, Goldstein DA, Zhou M, Fawzi AA, Jampol LM. Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma. JAMA Ophthalmol. 2019;137(2):194\u20138.","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"405_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1869-5760-3-59","volume":"3","author":"HS Jang","year":"2013","unstructured":"Jang HS, Sepah YJ, Sophie R, Bittencourt MG, Ferraz D, Hanout M, et al. Longitudinal spectral domain optical coherence tomography changes in eyes with intraocular lymphoma. J Ophthal Inflamm Infect. 2013;3(1):59.","journal-title":"J Ophthal Inflamm Infect"},{"key":"405_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40942-019-0169-8","volume":"5","author":"V Diaconita","year":"2019","unstructured":"Diaconita V, Rihani H, Mares V, Nehemy MB, Bakri SJ, Pulido JS. The use of anterior segment optical coherence tomography (ASOCT) in demonstrating recurrence of vitreoretinal lymphoma (VRL) in the anterior vitreous. Int J Retina Vitr. 2019;5:19. https:\/\/doi.org\/10.1186\/s40942-019-0169-8.","journal-title":"Int J Retina Vitr"},{"issue":"1","key":"405_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00006982-200202000-00007","volume":"22","author":"G Velez","year":"2002","unstructured":"Velez G, Chan CC, Csaky KG. Fluorescein angiographic findings in primary intraocular lymphoma. Retina. 2002;22(1):37\u201343.","journal-title":"Retina"},{"issue":"4","key":"405_CR32","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000472152","volume":"3","author":"R Venkatesh","year":"2017","unstructured":"Venkatesh R, Gurav P, Abhishek Dave P, Gandhi A. Capillary dropout: a novel fluorescein angiography finding in primary vitreoretinal lymphoma. Ocular Oncol Pathol. 2017;3(4):324\u20137.","journal-title":"Ocular Oncol Pathol"},{"issue":"3","key":"405_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1159\/000447412","volume":"236","author":"C Mapelli","year":"2016","unstructured":"Mapelli C, Invernizzi A, Barteselli G, Pellegrini M, Tabacchi E, Staurenghi G, et al. Multimodal imaging of vitreoretinal lymphoma. Ophthalmologica. 2016;236(3):166\u201374.","journal-title":"Ophthalmologica"},{"key":"405_CR34","first-page":"301","volume":"4","author":"C Yasuda","year":"2010","unstructured":"Yasuda C, Ueno S, Kondo M, Kondo N, Piao C-H, Terasaki H. Analyses of ERG in a patient with intraocular lymphoma. Clinical ophthalmol. 2010;4:301\u20136.","journal-title":"Clinical ophthalmol"},{"issue":"8","key":"405_CR35","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1007\/s10792-021-01828-8","volume":"41","author":"P Rishi","year":"2021","unstructured":"Rishi P, Maitra P, Das K, Rishi E, Manchegowda PT. Multimodal imaging characteristics in eyes with vitreoretinal lymphoma treated with intravitreal rituximab. Int Ophthalmol. 2021;41(8):2711\u201322.","journal-title":"Int Ophthalmol"}],"container-title":["International Journal of Retina and Vitreous"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40942-022-00405-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40942-022-00405-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T01:04:04Z","timestamp":1661562244000},"score":1,"resource":{"primary":{"URL":"https:\/\/journalretinavitreous.biomedcentral.com\/articles\/10.1186\/s40942-022-00405-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["405"],"URL":"https:\/\/doi.org\/10.1186\/s40942-022-00405-0","relation":{},"ISSN":["2056-9920"],"issn-type":[{"value":"2056-9920","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,26]]},"assertion":[{"value":"19 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}